SEC Form 4Coverage since Jun 4, 2026
$IBRX insider trading
Over the last 12 months, ImmunityBio insiders reported no purchases and 5 sales totaling $3.9M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $3.9M 5 events
- Events · 12m
- 5 Form 4 filings, grouped
- Insiders · 12m
- 3 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $IBRX · 12Mvia TradingView
Top insiders · 12m
Simon Barry J.—2× · $362K
Selecky Christobel—2× · $2.3M
Cohen Cheryl—1× · $1.2M
All insider trades
5 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Cohen CherylD | ▼ Sale | 131,210 | $9.5 | $1.2M | -51.1% | plan |
| Jul 1, 2026 | Selecky ChristobelD | ▼ Sale | 159,478 | $9.02 | $1.4M | -100% | plan |
| Jun 30, 2026 | Selecky ChristobelD | ▼ Sale | 96,722 | $9.01 | $871K | -100% | plan · 2 tranches |
| Jun 24, 2026 | Simon Barry J.D | ▼ Sale | 25,000 | $7.88 | $197K | -0.9% | plan |
| Jun 4, 2026 | Simon Barry J.D | ▼ Sale | 23,033 | $7.18 | $165K | -0.8% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $IBRX feed.